Showing results (1411-1420 of 1,502) with videos related to

Sort By:
Pageof 151
BMJ Neurology Open|October 10, 2025
Rationale and design of 'StAtins in Frail oldEr patients with ischemic Stroke or Transient ischemic attack-the Randomized Controlled Trial' (SAFEST-RCT)Susanna Rosa Prins, Birgit A Damoiseaux-Volman, Sarah E Vermeer, et al.
Circulation. Arrhythmia and Electrophysiology|October 15, 2025
High Rate Triggers Increased Atrial Release of BMP10, A Biomarker for Atrial Fibrillation and Stroke, and BMP10 Affects Ventricular CardiomyocytesLaura C Sommerfeld, Jessica Schrapers, Karl-Felix Müller, et al.
The Oncologist|March 24, 2018
Treatment and Survival of Patients with Colon Cancer Aged 80 Years and Older: A EURECCA International ComparisonNina C A Vermeer, Yvette H M Claassen, Marloes G M Derks, et al.
Cardiovascular Research|May 20, 2014
Gene-specific increase in the energetic cost of contraction in hypertrophic cardiomyopathy caused by thick filament mutationsE Rosalie Witjas-Paalberends, Ahmet Güçlü, Tjeerd Germans, et al.
Cancers|March 25, 2022
Topical Bimiralisib Shows Meaningful Cutaneous Drug Levels in Healthy Volunteers and Mycosis Fungoides Patients but No Clinical Activity in a First-in-Human, Randomized Controlled TrialSelinde S Wind, Manon A A Jansen, Melanie Rijsbergen, et al.
Clinical Genetics|January 29, 2013
Prenatal testing for Huntington's disease in the Netherlands from 1998 to 2008M C van Rij, P A M de Koning Gans, C M Aalfs, et al.
British Journal of Cancer|July 31, 2018
Treatment and survival of rectal cancer patients over the age of 80 years: a EURECCA international comparisonYvette H M Claassen, Nina C A Vermeer, Lene H Iversen, et al.
European Journal of Cancer (Oxford, England : 1990)|October 27, 2023
EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2023Johanna Latzka, Chalid Assaf, Martine Bagot, et al.
Blood|February 5, 2005
WHO-EORTC classification for cutaneous lymphomasRein Willemze, Elaine S Jaffe, Günter Burg, et al.
Blood|August 16, 2011
EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphomaWerner Kempf, Katrin Pfaltz, Maarten H Vermeer, et al.
Pageof 151